600201 Stock Overview
Engages in the research and development, production, and sale of veterinary products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Jinyu Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.20 |
| 52 Week High | CN¥10.95 |
| 52 Week Low | CN¥5.62 |
| Beta | 0.57 |
| 1 Month Change | 7.14% |
| 3 Month Change | 6.19% |
| 1 Year Change | -33.15% |
| 3 Year Change | -55.96% |
| 5 Year Change | -62.36% |
| Change since IPO | 536.50% |
Recent News & Updates
Recent updates
The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically
Sep 04
Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Sep 02Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge
Jun 16Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year
Apr 30There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price
Mar 21Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?
Feb 28Shareholder Returns
| 600201 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.0% | -1.7% | -0.5% |
| 1Y | -33.1% | -19.8% | 9.2% |
Return vs Industry: 600201 underperformed the CN Biotechs industry which returned -19.8% over the past year.
Return vs Market: 600201 underperformed the CN Market which returned 9.2% over the past year.
Price Volatility
| 600201 volatility | |
|---|---|
| 600201 Average Weekly Movement | 6.1% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600201 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600201's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,654 | Jing Zhang | www.jinyu.com.cn |
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and is headquartered in Hohhot, China.
Jinyu Bio-technology Co., Ltd. Fundamentals Summary
| 600201 fundamental statistics | |
|---|---|
| Market cap | CN¥8.02b |
| Earnings (TTM) | CN¥164.86m |
| Revenue (TTM) | CN¥1.35b |
48.8x
P/E Ratio6.0x
P/S RatioIs 600201 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600201 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.35b |
| Cost of Revenue | CN¥599.81m |
| Gross Profit | CN¥750.23m |
| Other Expenses | CN¥585.36m |
| Earnings | CN¥164.86m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 55.57% |
| Net Profit Margin | 12.21% |
| Debt/Equity Ratio | 0% |
How did 600201 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield54%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 11:18 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jinyu Bio-technology Co., Ltd. is covered by 25 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Jia Chen | Changjiang Securities Co. LTD. |
| Fu Yang | Chasing Securities |